글로벌 Churg-Strauss 증후군 치료 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 Churg-Strauss 증후군 치료 시장

처그-스트라우스 증후군 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 4.80%의 잠재적 성장률을 기록할 것으로 예상됩니다. 연구 개발에 대한 투자 증가가 시장 성장의 원인입니다.

척-스트라우스 증후군은 다발혈관염을 동반한 호산구성 과립종증으로도 알려져 있으며, 혈관에 염증을 일으키는 질환의 한 유형입니다. 이것은 필수적인 장기와 조직으로의 혈류를 차단합니다. 때로는 조직이 영구적으로 손상되기도 합니다. 천식은 척-스트라우스 증후군의 가장 흔한 징후로 알려져 있습니다. 

추그-스트라우스 증후군 및 기타 알레르기 반응의 발생률이 빠르게 증가함에 따라 2021년에서 2028년의 예측 기간 동안 시장 성장이 가속화될 것으로 예상됩니다. 마찬가지로 전 세계적으로 천식 발생률이 증가하고 노인 인구가 빠르게 증가함에 따라 추그-스트라우스 증후군 치료 시장 성장이 향상될 것으로 예측됩니다. 나아가 어린이의 추그-스트라우스 증후군 발생률이 증가하고 면역 관련 질환이 증가함에 따라 시장 성장률이 높아질 것으로 예상됩니다.

또한, 부비동 통증과 염증에 대한 정부 지출이 증가하고, 알레르기 반응 문제로 병원을 찾는 사람이 늘어나고, R&D 활동이 늘어나면서 2021년에서 2028년까지의 예측 기간 동안 처그-스트라우스 증후군 치료 시장 성장에 영향을 미칠 다양한 새로운 기회가 창출될 가능성이 높습니다.

However, the unfavorable reimbursement scenario and lack of awareness about the autoimmune disorder amongst people are expected to act as major restraints towards the growth of the churg-strauss syndrome treatment market, whereas the no specific tests available for diagnosis for churg strauss syndrome can challenge the growth of the target market in the above mentioned forecast period.

This churg-strauss syndrome treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the churg-strauss syndrome treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Churg-Strauss Syndrome Treatment Market Scope and Market Size

Churg-strauss syndrome treatment market is segmented on the basis of indication, diagnosis, treatment, route of administration, distribution channel and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• Based on indication, the churg-strauss syndrome treatment market can be segmented into acute ischemic stroke, cerebral insufficiency, alzheimer's disease, attention deficit-hyperactive disorder (ADHD) and others.
• On the basis of diagnosis, the churg-strauss syndrome treatment market can be segmented into blood test, imaging, biopsy, chest X-ray and CT scan.
• On the basis of treatment, the churg-strauss syndrome treatment market can be segmented into biologics, immunoglobulin, vaccines, steroid, corticosteroid, immunosuppressive drugs and others.
• The route of administration segment of the churg-strauss syndrome treatment market can be segmented into oral and injectable.
• Based on distribution channel, the churg-strauss syndrome treatment market can be segmented into hospital pharmacies, retail pharmacies and mail order pharmacies.
• On the basis of end users, the churg-strauss syndrome treatment market can be segmented into hospitals, laboratories, clinics, therapeutic usage, and others.

Churg-Strauss Syndrome Treatment Market Country Level Analysis

Churg-strauss syndrome treatment market is analyzed and market size information is provided by country by indication, diagnosis, treatment, route of administration, distribution channel and end users as referenced above.

The countries covered in the churg-strauss syndrome treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America leads the churg-strauss syndrome treatment market due to rapid rise in the asthma patients, change in environmental conditions and increase in the allergic reaction. Asia-Pacific region is expected to expand at a significant growth rate in the forecast period of 2021 to 2028 because of the increase in the prevalence of immunosuppressant disease as well as the hyper-eosinophilia related problems and rise in the incidences of granulomatosis.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Churg-strauss syndrome treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Churg-Strauss Syndrome Treatment Market Share Analysis

Churg-strauss syndrome treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to churg-strauss syndrome treatment market.

처그-스트라우스 증후군 치료 시장 보고서에 포함된 주요 기업으로는 Heron Therapeutics, Inc., Grifols, SA, GlaxoSmithKline plc, Novartis AG, Hikma Pharmaceuticals PLC, Avalon Pharma Private Limited, F. Hoffmann-La Roche Ltd., AstraZeneca, LGM Pharma, Taj Pharma 등이 있으며, 국내 및 글로벌 기업도 있습니다. 처그-스트라우스 증후군 치료 시장 점유율 데이터는 글로벌, 북미, 남미, 유럽, 아시아 태평양(APAC) 및 중동 및 아프리카(MEA)에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-63108